Ocugen, Inc.

Pursuing Innovative Ocular Biotherapeutics

Canada
Ocugen, Inc. Announces Initiation of Rolling Submission to Health Canada for COVAXIN™
Read the press release →
Phase 3 Results
Phase 3 Results for COVAXIN™
Vaccine Candidate Now Available
Read the press release →
Mission - Vaccine
Our Mission is to Develop Gene
Therapies to Cure Blindness
Diseases and Develop a Vaccine
to Save Lives from COVID-19
Mission - General
Our Mission is to Develop
Gene Therapies to Cure Blindness
Diseases and Develop a Vaccine
to Save Lives from COVID-19
Mission - Gene Therapies
Our Mission is to Develop Gene
Therapies to Cure Blindness
Diseases and Develop a Vaccine
to Save Lives from COVID-19
previous arrowprevious arrow
next arrownext arrow

COVAXIN News

Press Releases

Sign up to receive email alerts with the latest news from Ocugen Subscribe